OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Lightspeed is in discussions to lead the funding round, sources say.

Lightspeed is in discussions to lead the funding round, sources say.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *